Healthtech funding in Q3 2015
European Healthtech startup funding raised during Q3 2015.
In Q3 2015, 58 European Healthtech companies closed 61 funding rounds and raised €718M in equity funding (excluding debt and grants), up 193.7% versus Q3 2014. Switzerland led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 20 Nov 2026.
Equity funding
€718M
+193.7% vs Q3 2014 · excl. debt & grants
Funding rounds
61
+117.9% vs Q3 2014
Companies
58
Top country
Switzerland
Rank among sectors
#2
12.7% of sector funding
Top-10 round share
69.3%
of disclosed capital
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, Q3 2015 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jul | €119M | 21 |
| Aug | €207M | 11 |
| Sep | €405M | 29 |
Top countries
by € raisedHealthtech — top countries by capital, Q3 2015 — interactive chart.
Data table
| Healthtech — top countries by capital, Q3 2015 | |
|---|---|
| Switzerland | €219M |
| UK | €135M |
| France | €95M |
| Netherlands | €85M |
| Israel | €64M |
| Spain | €39M |
| Sweden | €37M |
| Belgium | €30M |
Stage mix
by € raisedHealthtech — stage mix, Q3 2015 — interactive chart.
Data table
| Healthtech — stage mix, Q3 2015 | |
|---|---|
| Series C | €293M |
| Growth/Late | €166M |
| Series A | €137M |
| Series B | €68M |
| Series D+ | €25M |
| Early VC | €20M |
| Grant | €14M |
| Seed | €11M |
Top deals
largest disclosed rounds in Q3 2015| Company | Stage | Date | Amount |
|---|---|---|---|
| CeQur | Series C | Sep 2015 | €89M |
| Benevolent | Growth/Late | Aug 2015 | €80M |
| Merus | Series C | Aug 2015 | €73M |
| ADC Therapeutics | Growth/Late | Sep 2015 | €71M |
| Sanifit | Series C | Sep 2015 | €37M |
| Bima | Series C | Jul 2015 | €34M |
| GenSight Biologics | Series B | Jul 2015 | €32M |
| Biom'Up | Series C | Sep 2015 | €31M |
| Therachon | Series A | Sep 2015 | €31M |
| Novadip Biosciences | Series A | Sep 2015 | €28M |
| Asceneuron | Series A | Sep 2015 | €27M |
| Replimune | Series A | Sep 2015 | €27M |
| LifeBond | Series D+ | Aug 2015 | €25M |
| InSphero | Series C | Jul 2015 | €18M |
| Kuros Biosurgery | Growth/Late | Aug 2015 | €14M |
Top investors
most active in Q3 2015, by deal count- High-Tech Gründerfonds (HTGF)5 deals
- Forbion2 deals
- Go Beyond Early Stage Investing2 deals
- Italian Angels for Growth2 deals
- Life Sciences Partners2 deals
- Limburg Business Development Fund2 deals
- LionBird2 deals
- Lundbeckfond Ventures2 deals
- Novartis Venture Fund2 deals
- Sofinnova Partners2 deals